Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Akero Therapeutics Inc | 365,000 | 365,000 | 0 | 10,154 | 14,775 | 8.09% | +4,621 |
| Viridian Therapeutics, Inc(VRDN) | 1,974 | 1,974 | 0 | 38 | 27 | 0.01% | -11 |
| Casi Pharmaceuticals Inc(CASIF) | 1,329,383 | 1,329,383 | 0 | 3,762 | 2,871 | 1.57% | -891 |
| Kymera Therapeutics Inc(KYMR) | 146,332 | 146,332 | 0 | 5,887 | 4,005 | 2.19% | -1,882 |
| Allogene Therapeutics Inc | 3,448,275 | 3,448,275 | 0 | 7,345 | 5,034 | 2.76% | -2,310 |
| Edgewise Therapeutics Inc(EWTX) | 585,000 | 585,000 | 0 | 15,620 | 12,870 | 7.05% | -2,749 |
| Cullinan Therapeutics Inc(CGEM) | 634,558 | 634,558 | 0 | 7,729 | 4,804 | 2.63% | -2,925 |
| Centessa Pharmaceuticals Inc | 1,253,379 | 1,253,379 | 0 | 20,994 | 18,024 | 9.87% | -2,971 |
| Corvus Pharmaceuticals Inc(CRVS) | 1,581,233 | 1,581,233 | 0 | 8,460 | 5,028 | 2.75% | -3,431 |
| Structure Therapeutics Inc | 420,000 | 420,000 | 0 | 11,390 | 7,270 | 3.98% | -4,120 |
| Bicara Therapeutics Inc | 950,000 | 950,000 | 0 | 16,549 | 12,379 | 6.78% | -4,170 |
| Rapt Therapeutics Inc | 12,500,000 | 12,500,000 | 0 | 19,750 | 15,250 | 8.35% | -4,500 |
| Alumis Inc | 4,202,670 | 4,202,670 | 0 | 33,033 | 25,804 | 14.14% | -7,229 |
| CG Oncology, Inc.(CGON) | 2,221,474 | 2,221,474 | 0 | 63,712 | 54,404 | 29.80% | -9,308 |